Skip to content
PubMed This is a summary of 91 peer-reviewed journal articles Updated
Nephrology

Calciphylaxis: A Patient Guide

At a Glance

Calciphylaxis is a rare, serious condition in which small blood vessels supplying the skin become blocked, causing severe pain and wounds that may not heal. It needs prompt evaluation and coordinated care for wounds, pain, kidney function, mineral balance, and medication safety.

Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare but deeply serious condition that primarily affects people with advanced kidney disease or those on dialysis (though a rare “non-uremic” form can occur in people with normal kidney function). It is characterized by the buildup of calcium in the walls of the small blood vessels that supply the skin and the fatty tissue beneath it. As these vessels narrow and develop small blood clots, they become blocked, cutting off the vital flow of oxygen and nutrients to the tissue. This process, known as ischemia, leads to tissue death and the formation of non-healing, painful wounds [1][2].

The defining feature of calciphylaxis is an intensity of pain that often feels “out of proportion” to what is visible on the surface. Many patients experience deep, burning, or throbbing sensations even before the skin begins to change color or break down. This pain is real, and it is a direct result of the nerves and tissues struggling to survive without adequate blood flow. Validating and managing this pain is not just a matter of comfort; it is a fundamental part of the medical treatment plan [3][4].

Because the disease can progress quickly, early diagnosis and immediate medical evaluation are critical. A key part of initial treatment often involves a supervised “medication sweep” to review potential triggers. This may include evaluating the blood thinner warfarin (Coumadin) or certain calcium-containing supplements, as these can interfere with the body’s natural ability to prevent vessel calcification. However, you must never stop warfarin, phosphate binders, or any medication on your own. Abruptly stopping blood thinners can cause life-threatening clots or strokes, especially if you have a mechanical heart valve. Any medication changes must be carefully coordinated by your nephrologist and prescribing doctors [5][6].

Living with calciphylaxis requires a dedicated, multidisciplinary team of specialists, including kidney doctors, skin experts, wound care nurses, and pain management specialists. While the diagnosis is challenging, a coordinated approach that focuses on meticulous wound care, aggressive pain control, and managing your mineral balance provides the best path forward. You and your caregivers are central members of this team, and your observations about new skin changes or shifts in pain levels are vital to your ongoing care [7][8].

Common questions in this guide

What is calciphylaxis, and why does it cause such severe pain?
Calciphylaxis happens when calcium builds up in and narrows small blood vessels supplying the skin and fatty tissue. Reduced blood flow can injure tissue and nerves, causing deep, burning, or throbbing pain that may be much worse than the skin looks.
What are the warning signs of calciphylaxis?
Severe or unusual pain, especially in skin that looks normal or only slightly red, can be an early warning sign. Later signs may include skin color changes, painful wounds, and tissue that does not heal; new symptoms need prompt medical evaluation.
Who is most at risk for calciphylaxis?
Calciphylaxis most often affects people with advanced kidney disease or those receiving dialysis. A rare non-uremic form can occur in people with normal kidney function, and clinicians may also review medicines such as warfarin and calcium-containing supplements when assessing risk.
Can I stop warfarin or phosphate binders if calciphylaxis is suspected?
No. Do not stop warfarin, phosphate binders, calcium supplements, or any other medicine without speaking with the prescribing clinician and kidney specialist; stopping a blood thinner suddenly can cause dangerous clots or stroke, especially with a mechanical heart valve.
How is calciphylaxis treated?
Care usually involves a coordinated team that focuses on careful wound care, strong pain control, and management of mineral balance. The team may also review medicines and dialysis, with a nephrologist, skin specialist, wound care nurse, and pain specialist working together.
How can my care team monitor calciphylaxis?
Your team may track changes in pain, skin color, wounds, and healing while reviewing your medicines, dialysis, and mineral balance. Tell the team promptly about new skin changes or a change in pain, because the condition can worsen quickly.

Get notified when new evidence is published on Calciphylaxis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working Group.

    Huish S, Moore S, Alfieri C, et al.

    Clinical kidney journal 2025; (18(12)):sfaf338 doi:10.1093/ckj/sfaf338.

    PMID: 41367922
  2. 2

    Diagnosing Calciphylaxis: A Review With Emphasis on Histopathology.

    Bahrani E, Perkins IU, North JP

    The American Journal of dermatopathology 2020; (42(7)):471-480 doi:10.1097/DAD.0000000000001526.

    PMID: 32604207
  3. 3

    Correlation between clinical and pathological features of cutaneous calciphylaxis.

    Dutta P, Chaudet KM, Nazarian RM, et al.

    PloS one 2019; (14(6)):e0218155 doi:10.1371/journal.pone.0218155.

    PMID: 31194797
  4. 4

    Calciphylaxis: from the disease to the diseased.

    Oliveira TM, Frazão JM

    Journal of nephrology 2015; (28(5)):531-40 doi:10.1007/s40620-015-0192-2.

    PMID: 25835730
  5. 5

    Ten tips on how to deal with calciphylaxis patients.

    Chewcharat A, Nigwekar SU

    Clinical kidney journal 2025; (18(4)):sfaf098 doi:10.1093/ckj/sfaf098.

    PMID: 40600068
  6. 6

    Perioperative Management of Calciphylaxis: Literature Review and Treatment Recommendations.

    Strand N, Maloney J, Wu S, et al.

    Orthopedic reviews 2022; (14(3)):37573 doi:10.52965/001c.37573.

    PMID: 36034726
  7. 7

    The application of MDT model for calciphylaxis management in patients with end-stage renal disease.

    Pan Y, Wang H, Ye Y, et al.

    International wound journal 2023; (20(9)):3717-3723 doi:10.1111/iwj.14265.

    PMID: 37309083
  8. 8

    An Update on Calciphylaxis.

    García-Lozano JA, Ocampo-Candiani J, Martínez-Cabriales SA, Garza-Rodríguez V

    American journal of clinical dermatology 2018; (19(4)):599-608 doi:10.1007/s40257-018-0361-x.

    PMID: 29808451

This page is for informational purposes only and does not constitute medical advice. Because calciphylaxis can worsen quickly, contact your kidney or wound-care team promptly about new pain or skin changes, and never change medicines without medical guidance.